化学发光法与细胞间接免疫荧光法检测儿童肾病综合征血清抗Nephrin抗体的比较研究

doi:10.12372/jcp.2026.26e0171

Abstract

Abstract:

Objective To compare the performance differences of the chemiluminescence (CL) method and the cell-based assay (CBA) method in detecting serum anti-Nephrin antibodies in children with nephrotic syndrome (NS). Methods A total of 34 children with nephrotic syndrome (NS) who visited the Pediatric Department from February 2023 to January 2025 were included, along with 18 healthy control children. Serum anti-Nephrin antibodies were detected by CL method and CBA method respectively. The children were grouped according to their urine protein levels and renal pathological types. The differences in positive rates between the groups were compared using the CL method and CBA method. The correlation and consistency between the CL method and CBA method were analyzed. The clinical characteristics of NS children with single positive by CL method and double positive by both CL method and CBA method were compared. Results Among the 34 children with NS, there were 26 boys and 8 girls. The average age was (11.7±3.9) years, and the median disease duration was 5.00 (2.75-9.00) years. There were 19 cases in the urine protein-negative group, 5 cases in the mild to moderate proteinuria group, and 10 cases in the heavy proteinuria group. There were 5 cases of focal segmental glomerulosclerosis (FSGS), 13 cases of minimal change disease (MCD), and 16 cases of minor glomerular abnormalities. The 18 healthy control children tested negative for serum anti-Nephrin antibodies using both the CL method and the CBA method. Among the 34 children with NS, the overall positive rate of CL method was 44.1% (15/34), which was higher than that by the CBA method (11.8%, 4/34), with a statistically significant difference (P=0.003). In NS patients stratified by urinary protein level (negative, mild-to-moderate, heavy), the positive rates of serum anti-Nephrin antibody were 10.5% (2/9), 80% (4/5), 90% (9/10) by CL method and 5.3% (1/19), 0 (0), 30% (3/10) by CBA method, respectively. Among the mild-to-moderate proteinuria and heavy proteinuria groups, the positive rate of the CL method was higher than that of the CBA method, and the difference was statistically significant (P<0.05). When comparing the results grouped by renal pathological types (FSGS, MCD, minor glomerular abnormalities), the positive rates of anti-Nephrin antibodies detected by the CL method were 80.00% (4/5), 46.2% (6/13), and 31.3% (5/16), respectively, while those by the CBA method were 60.00% (3/5), 0 (0), and 6.3% (1/16), respectively. Among them, the positive rate of the CL method in the MCD group was higher than that of the CBA method (P=0.015). Spearman rank correlation analysis showed that the serum anti-Nephrin antibody levels measured by the CL method and the CBA method were significantly positively correlated (r_s=0.57, P<0.001). The consistency analysis of the two detection methods results revealed that the κ value was 0.63 (P<0.001), indicating good consistency. There were no significant differences in the clinical characteristics among NS children with single positive results by the CL method, double positive results by the CL method and the CBA method. Conclusions Both CL method and CBA method can be used to detect anti-Nephrin antibodies and the results are related. However, the CL method has higher sensitivity and can identify a wider range of antibody-positive children, and can be used as a preferred detection and monitoring tool for autoimmune podocyte injury in children with NS.

Key words: nephrotic syndrome, anti-Nephrin antibody, chemiluminescence method, cell-based assay, comparative study, child

CLC Number:

LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay[J].Journal of Clinical Pediatrics, 2026, 44(8): 682-689.

Figures/Tables 2

Table 1

Table 2

References 20

[1]	Vivarelli M, Gibson K, Sinha A, et al. Childhood nephrotic syndrome[J/OL]. Lancet, 2023, 402(10404): 809-824. https://doi.org/10.1016/S0140-6736(23)01051-6.
[2]	Watts AJB, Keller KH, Lerner G, et al. Discovery of autoantibodies targeting Nephrin in minimal change disease supports a novel autoimmune etiology[J/OL]. J Am Soc Nephrol, 2022, 33(1): 238-252. https://doi.org/10.1681/ASN.2021060794.
[3]	Horinouchi T, Nozu K, Iijima K. Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies[J/OL]. Clin Exp Nephrol, 2025, 29(5): 534-540. https://doi.org/10.1007/s10157-025-02645-4.
[4]	Shu Y, Huang J, Jiang L, et al. Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis[J/OL]. Kidney Int, 2025, 108(3): 433-444. https://doi.org/10.1016/j.kint.2025.02.028.
[5]	Liu P, Liu S, Dalal V, et al. Evaluation of methodologies in anti-nephrin autoantibody detection[J/OL]. Kidney Int, 2025, 108(3): 485-490. https://doi.org/10.1016/j.kint.2025.05.018.
[6]	Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome[J/OL]. Pediatr Nephrol, 2023, 38(3): 877-919. https://doi.org/10.1007/s00467-022-05739-3.
[7]	Floege J, Gibson KL, Vivarelli M, et al. KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children[J/OL]. Kidney Int, 2025, 107(5S): S241-S289. https://doi.org/10.1016/j.kint.2024.11.007.
[8]	中华医学会儿科学分会肾脏学组, 中华儿科杂志编辑委员会. 中国儿童慢性肾脏病早期筛查临床实践指南(2021版)[J/OL]. 中华儿科杂志, 2022, 60(9): 858-868. https://doi.org/10.3760/cma.j.cn112140-20220714-00647.
	Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Clinical practice guideline for early screening of pediatric chronic kidney disease in China (version 2021) [J]. Zhonghua Erke Zazhi, 2022, 60(9):858-868. https://doi.org/10.3760/cma.j.cn112140-20220714-00647.
[9]	中华医学会儿科学分会肾脏学组. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)[J/OL]. 中华儿科杂志, 2017, 55(10): 729-734. https://doi.org/10.3760/cma.j.issn.0578-1310.2017.10.003.
	Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association. Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing/steroid-dependent nephrotic syndrome in children (2016) [J]. Zhonghua Erke Zazhi, 2017, 55(10): 729-734. https://doi.org/10.3760/cma.j.issn.0578-1310.2017.10.003.
[10]	Aoyagi J, Kanai T, Ito T, et al. Glucocorticoid effects on bone strength in children with renal diseases[J/OL]. Nephrology (Carlton), 2021, 26(2): 119-125. https://doi.org/10.1111/nep.13832.
[11]	唐毓贤, 龚粤婷, 聂晓晶. 儿童原发性肾病综合征激素治疗反应预测因子的研究进展[J/OL]. 中华儿科杂志, 2023, 61(12) : 1144-1147. https://doi.org/10.3760/cma.j.cn112140-20230824-00126.
	Tang YX, Gong YT, Nie XJ. Research progress on predictors of hormone efficacy in children with primary nephrotic syndrome[J]. Zhonghua Erke Zazhi, 2023, 61(12): 1144-1147. https://doi.org/10.3760/cma.j.cn112140-20230824-00126.
[12]	Hengel FE, Dehde S, Lassé M, et al. Autoantibodies targeting Nephrin in podocytopathies[J/OL]. N Engl J Med, 2024, 391(5): 422-433. https://doi.org/10.1056/NEJMoa2314471.
[13]	Hengel FE, Dehde S, Yilmaz A, et al. Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy[J/OL]. Kidney Int, 2025, 107(6): 1099-1103. https://doi.org/10.1016/j.kint.2025.01.019.
[14]	Chen Q, Chen S, Ye Q, et al. Anti-nephrin antibody: a potential biomarker of minimal change disease[J/OL]. Clin Kidney J, 2025, 18(3): sfaf012. https://doi.org/10.1093/ckj/sfaf012.
[15]	上海市医学会检验医学分会. 新型冠状病毒核酸和抗体检测临床应用专家共识[J/OL]. 国际检验医学杂志, 2020, 41(14): 1665-1669. https://doi.org/10.3969/j.issn.1673-4130.2020.14.001.
	Shanghai Medical Association Laboratory Medicine Branch. Expert consensus on the clinical application of nucleic acid and antibody detection for novel coronavirus[J]. Guoji Jianyan Yixue Zazhi, 2020, 41(14): 1665-1669. https://doi.org/10.3969/j.issn.1673-4130.2020.14.001.
[16]	Huergo LF, Selim KA, Conzentino MS, et al. Magnetic bead-based immunoassay allows rapid, inexpensive, and quantitative detection of human SARS-CoV-2 antibodies[J/OL]. ACS Sens, 2021, 6(3): 703-708. https://doi.org/10.1021/acssensors.0c02544.
[17]	中国医疗保健国际交流促进会基层检验技术标准化分会. 基层医疗机构开展自身抗体检测与应用的专家共识[J/OL]. 中华预防医学杂志, 2024, 58(12): 1835-1852. https://doi.org/10.3760/cma.j.cn112150-20240907-00715.
	Grassroots Inspection Technology Standardization Branch of China International Exchange and Promotive Association for Medical and Health Care. Expert consensus on autoantibody detection and application in primary healthcare institutions[J/OL]. Zhonghua Yufangyixue Zazhi, 2024, 58(12) : 1835-1852. https://doi.org/10.3760/cma.j.cn112150-20240907-00715.
[18]	Gao F, Zhang Y, Lv J, et al. How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases[J/OL]. Ann Transl Med, 2023, 11(7): 281. https://doi.org/10.21037/atm-21-3072.
[19]	Molina RD, Conzatti LP, Da Silva APB, et al. Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays[J/OL]. Mult Scler Relat Disord, 2020, 38: 101858. https://doi.org/10.1016/j.msard.2019.101858.
[20]	Dähnrich C, Saschenbrecker S, Gunnarsson I, et al. Development of a standardized chemiluminescence immunoassay for the detection of autoantibodies against human M-type phospholipase A₂ receptor in primary membranous nephropathy[J/OL]. Kidney Int Rep, 2020, 5(2): 182-188. https://doi.org/10.1016/j.ekir.2019.11.008.

项目	尿蛋白阴性组(n=19)	轻中度蛋白尿组(n=5)	大量蛋白尿组(n=10)	统计量	P
年龄[M(P₂₅~P₇₅)]/岁	12.0(9.0~14.0)	16.0(11.5~17.0)	11.5(7.3~14.5)	H=3.75	0.154
男性[n(%)]	13(68.4)	5(100)	8(80.0)	－	0.480¹⁾
白蛋白[M(P₂₅~P₇₅)]/g·L^-1	41.3(37.1~42.3)	29.7(28.7~34.8)	22.3(17.1~26.6)	H=23.10	<0.001
胆固醇[M(P₂₅~P₇₅)]/mmol·L^-1	4.8(3.7~6.2)	5.0(4.9~6.2)	8.3(7.2~9.4)	H=15.35	<0.001
肌酐($\bar{x}±s$)/μmol·L^-1	43.2±12.7	50.0±14.7	46.9±18.0	F=0.51	0.606
eGFR[M(P₂₅~P₇₅)]/mL·min^-1·1.73m^-2	179.8(152.5~196.7)	215.2(189.5~238.0)	175.8(159.9~192.1)	H=3.51	0.173
24 h尿蛋白定量[M(P₂₅~P₇₅)]/g	0.07(0.05~0.11)	1.3(1.1~1.5)	8.0(3.0~13.3)	H=25.67	<0.001
经体表面积校正的24 h尿蛋白定量 [M(P₂₅~P₇₅)]/mg·m^-2·d^-1	60.0(30.0~85.0)	761.0(586.5~1081.0)	5383.0(3395.0~7690.0)	H=26.33	<0.001
肾脏病理[n(%)]				－	0.026¹⁾
肾小球轻微病变	11(57.9)	0	5(50.00)
MCD	6(31.6)	5(100)	2(20.0)
FSGS	2(10.5)	0	3(30.0)
抗Nephrin抗体(CBA法)[n(%)]				－	0.066¹⁾
1∶10	1(5.3)	0	0
1∶32	0	0	3(30.0)
阴性	18(94.7)	5(100)	7(70.0)
抗Nephrin抗体(CL法) [M(P₂₅~P₇₅)]/AU·mL^-1	3.0(3.0~6.0)	25.0(15.5~30.5)	30.0(23.5~52.0)	H=16.18	<0.001
阳性[n(%)]	2(10.5)	4(80.0)	9(90.0)	－	<0.001¹⁾
阴性[n(%)]	17(89.5)	1(20.0)	1(10.0)

项目	单阳性组(n=11)	双阳性组(n=4)	统计量	P
病程($\bar{x}±s$)/年	6.33±4.09	3.67±3.68	t=1.14	0.275
白蛋白($\bar{x}±s$)/g·L^-1	26.9±6.1	21.0±9.8	t=1.42	0.181
胆固醇($\bar{x}±s$)/mmol·L^-1	6.9±2.2	7.6±1.4	t=0.57	0.581
肌酐($\bar{x}±s$)/μmol·L^-1	45.4±13.9	59.4±16.4	t=1.65	0.122
eGFR($\bar{x}±s$)/mL·min^-1·1.73m^-2	193.6±27.1	148.5±34.7	t=2.66	0.020
抗Nephrin抗体(CL法)[M(P₂₅~P₇₅)]/AU·mL^-1	25.0(24.0~31.0)	64.0(43.0~126.3)	Z=2.88	0.004
24 h尿蛋白定量（经体表面积校正） [M(P₂₅~P₇₅)]/mg·m^-2·d^-1	2 090.0(761.0~5 766.0)	7 770.0(1 259.0~14 627.5)	Z=1.04	0.296
24 h尿蛋白定量[M(P₂₅~P₇₅)]/g	1.6(1.1~9.9)	11.9(1.6~17.6)	Z=1.18	0.240

A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 20

Related Articles 15

Metrics

Comments

Recommended 0

[1]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[2]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[3]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[4]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[5]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[6]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[7]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[8]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[9]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[10]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[11]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[12]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[13]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[14]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.
[15]	LI Jian, LI Tao, HE Lulu, WU Lei, HU Tianjiao, HUANG Yixuan, LIN Xinrong, SHEN Qiyang, PAN Sirui, XIE Nan, ZHOU Jianfeng, ZHOU Chunlei, ZHOU Li. A retrospective analysis of 50 cases of malignant rhabdoid tumor in children: clinical features, treatment response and prognostic factors [J]. Journal of Clinical Pediatrics, 2026, 44(6): 499-507.